<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03690349</url>
  </required_header>
  <id_info>
    <org_study_id>271/2560(EC4)</org_study_id>
    <nct_id>NCT03690349</nct_id>
  </id_info>
  <brief_title>Mold Sensitization Associated Severe Asthma Exacerbation</brief_title>
  <official_title>Is Mold Sensitization Associated With Severe Asthma Exacerbation in Children?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mahidol University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mahidol University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Mold sensitization is associated with severe asthma exacerbation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Mold sensitization has been reported to be one of the factors that is associated with severe
      asthma exacerbation (SAE). The objective is to identify the factors that are associated with
      SAE in asthmatic children particularly mold sensitization.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2017</start_date>
  <completion_date type="Actual">September 23, 2018</completion_date>
  <primary_completion_date type="Actual">April 30, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Association between mold sensitization and severe asthma exacerbation</measure>
    <time_frame>1 year</time_frame>
    <description>Compare mean wheal diameter (mm.) of skin prick test of mold allergen extracts between the group with severe asthma exacerbation and the group without severe asthma exacerbation</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">102</enrollment>
  <condition>Asthma</condition>
  <arm_group>
    <arm_group_label>Skin test in severe asthma exacerbation</arm_group_label>
    <description>Skin test in asthmatic children hospitalized due to severe asthma exacerbation in a preceding year</description>
  </arm_group>
  <arm_group>
    <arm_group_label>skin test in outpatient</arm_group_label>
    <description>Skin test in asthmatic children without severe asthma exacerbation in a preceding year</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Skin test</intervention_name>
    <description>Demographic data review, Disease severity evaluation, Treatment evaluation and Skin prick test for 16 common aeroallergens</description>
    <arm_group_label>Skin test in severe asthma exacerbation</arm_group_label>
    <arm_group_label>skin test in outpatient</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Asthmatic children aged 1-15 years old from Pediatric Allergy and Immunology division
        devided in to 2 groups: 1. hospitalized due to severe asthma exacerbation in a preceding
        year and 2. without severe asthma exacerbation in a preceding year
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Asthmatic children aged 1-15 years old from Pediatric Allergy and Immunology division
             with hospitalized due to severe asthma exacerbation in a preceding year and without
             severe asthma exacerbation in a preceding year

        Exclusion Criteria:

          -  Other serious systemic diseases, pregnant, lactation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>15 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>September 25, 2018</study_first_submitted>
  <study_first_submitted_qc>September 27, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 1, 2018</study_first_posted>
  <last_update_submitted>March 13, 2019</last_update_submitted>
  <last_update_submitted_qc>March 13, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 15, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mahidol University</investigator_affiliation>
    <investigator_full_name>Nualanong Visitsunthorn</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>severe asthma exacerbation</keyword>
  <keyword>Mold sensitization</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asthma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

